CD8+ Cancer Research Results
CD8+, CD8+ T cell: Click to Expand ⟱
| Source: |
| Type: T cell |
CD8+ T cells are "end effectors" of cancer immunity.
Cytotoxic T cells expressing cell-surface CD8 are the most powerful effectors in the anticancer immune response and form the backbone of current successful cancer immunotherapies.
CD8+ T cells, also known as cytotoxic T lymphocytes (CTLs), play a crucial role in the immune response against cancer. They are responsible for identifying and killing cancer cells that present abnormal antigens, which can arise from mutations or viral infections.
|
HCC, Hepatocellular Carcinoma: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
Hif1a↓, AFP↑, hepatoP↑, STAT3↓, JAK2↓, *CD8+↑, ChemoSen↑, Dose↝, angioG↓,
TumCG↓, CD4+↑, CD8+↑, PD-L1↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Proliferation, Differentiation & Cell State ⓘ
STAT3↓, 1, TumCG↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, Hif1a↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1, JAK2↓, 1, PD-L1↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, Dose↝, 1,
Clinical Biomarkers ⓘ
AFP↑, 1, PD-L1↓, 1,
Functional Outcomes ⓘ
hepatoP↑, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 13
Pathway results for Effect on Normal Cells:
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 1
Scientific Paper Hit Count for: CD8+, CD8+ T cell
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:10 Cells:% prod#:% Target#:344 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page